Valacyclovir Hydrochloride

盐酸伐昔洛韦

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameValacyclovir Hydrochloride
Drug Alias NameVapridol盐酸伐西洛韦Valacyclovir盐酸发昔洛韦Valherpes +[21] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsSchizophreniaPsychotic DisordersCognitive Dysfunction +[24] 
Global Approved IndicationsHerpes LabialisHerpes SimplexHerpes Genitalis
Approved Indications in ChinaHerpes Simplex
Original Approved Country/TerritoryUnited States
Original Approved Date1995/06/23
Country/TerritoryCanadaUnited StatesSweden +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoInstituto OncoclinicasGlaxosmithkline Plc +[9] 
Inactive CompaniesUtah State UniversityRadboud University Medical CenterUniversity Medical Center Groningen +[19] 
Active IndicationsCognitive DysfunctionAcute PainStomatitis +[12] 
Inactive IndicationsSchizophreniaPsychotic DisordersBipolar Disorder +[12] 

Other Information

ATC CodeJ05AB11
Related LinksWikipediaDrugBankKEGG